| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88ada06aba45f224cb05c3c22028188e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3822941404a0bc1182f21ce7bd0081d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0262041d68ded8075b9756d5c53a0f81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dc146b35d8a2f3bafd0b0daf9ed1612 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6139b60c7f59ec5462f006c68d50a55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21f40eeaa690644cc3a8f70d6b85c33f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6165dd62f0e730d119ba9cc09a1d5638 |
| publicationDate |
2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007020884-A1 |
| titleOfInvention |
BIFIDOBACTERIUM OR LACTIC ACID BACTERIUM HAVING EFFECT OF PREVENTING INFECTION VIA β-DEFENSIN AND FOOD/PHARMACEUTICAL COMPOSITION CONTAINING THE SAME |
| abstract |
It is intended to provide a Bifidobacterium or lactic acid bacterium having an effect of preventing infection by increasing the expression level of β-defensin. By sensitizing an animal cell to this in advance or simultaneously, the expression level of β-defensin can be dramatically increased upon infection with a large amount of a pathogenic bacterium such as E. coli. Further, it is intended to provide a food/pharmaceutical composition containing the Bifidobacterium and/or lactic acid bacterium as an active ingredient and having the effect of preventing infection by increasing the expression level of β-defensin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10982184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015087919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526752-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7080296-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013530177-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021035992-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10517907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015087919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016194692-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011157816-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014526242-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019137700-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014159481-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010130662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016190804-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014068545-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2397145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016194692-A1 |
| priorityDate |
2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |